Beta Bionics (NASDAQ:BBNX) Upgraded by Baird R W to Hold Rating

Baird R W upgraded shares of Beta Bionics (NASDAQ:BBNX) to a hold rating in a research report sent to investors on Thursday morning,Zacks.com reports.

A number of other research analysts have also recently commented on BBNX. Robert W. Baird began coverage on Beta Bionics in a research note on Thursday. They set a “neutral” rating and a $20.00 target price on the stock. LADENBURG THALM/SH SH began coverage on Beta Bionics in a research note on Thursday. They issued a “neutral” rating and a $20.00 price objective on the stock.

Beta Bionics Price Performance

BBNX opened at $20.87 on Thursday. Beta Bionics has a one year low of $20.84 and a one year high of $24.50.

Insider Buying and Selling

In other news, insider Mike Mensinger acquired 33,350 shares of the company’s stock in a transaction that occurred on Friday, January 31st. The shares were bought at an average price of $17.00 per share, with a total value of $566,950.00. Following the completion of the purchase, the insider now directly owns 59,019 shares in the company, valued at $1,003,323. This trade represents a 129.92 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, major shareholder Hadley Harbor Aggre Wellington bought 1,000,000 shares of the stock in a transaction on Friday, January 31st. The shares were bought at an average price of $17.00 per share, with a total value of $17,000,000.00. Following the acquisition, the insider now owns 3,901,599 shares of the company’s stock, valued at $66,327,183. This trade represents a 34.46 % increase in their ownership of the stock. The disclosure for this purchase can be found here.

About Beta Bionics

Beta Bionics, Inc is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.